WO2012167656A1 - 抗辐射螺旋藻多糖有机生物碘及其应用 - Google Patents

抗辐射螺旋藻多糖有机生物碘及其应用 Download PDF

Info

Publication number
WO2012167656A1
WO2012167656A1 PCT/CN2012/073504 CN2012073504W WO2012167656A1 WO 2012167656 A1 WO2012167656 A1 WO 2012167656A1 CN 2012073504 W CN2012073504 W CN 2012073504W WO 2012167656 A1 WO2012167656 A1 WO 2012167656A1
Authority
WO
WIPO (PCT)
Prior art keywords
iodine
spirulina
radiation
polysaccharide
spirulina polysaccharide
Prior art date
Application number
PCT/CN2012/073504
Other languages
English (en)
French (fr)
Inventor
赵波
Original Assignee
深圳市兆博有机生物碘盐技术开发中心
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳市兆博有机生物碘盐技术开发中心 filed Critical 深圳市兆博有机生物碘盐技术开发中心
Publication of WO2012167656A1 publication Critical patent/WO2012167656A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/60Edible seaweed
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • A23L33/165Complexes or chelates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734Alginic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Definitions

  • the invention relates to an anti-radiation spirulina polysaccharide organic biological iodine and an application thereof.
  • BACKGROUND OF THE INVENTION British scientist Beverly once predicted that "the two invisible killers of human beings are radiation and fatigue", human beings are in different degrees of electromagnetic radiation in mobile phones, refrigerators, televisions, computers, fluorescent lamps, microwave ovens, electromagnetic waves, air conditioners, vacuum cleaners, etc. In the range, plus the radiation generated in nature, after a long time, it causes brain damage, causing fatigue, tinnitus, eye disease, headache and swelling.
  • gliomas are a type of brain cancer.
  • the radiated electromagnetic waves heat the body tissue and cause injury.
  • Spirulina has strong anti-radiation and anti-mutagenicity. Spirulina is irradiated with different arc radiation. No inhibition of Spirulina growth is observed when the irradiation intensity reaches 100 Gy (100 k rad). It shows that Spirulina has strong radiation resistance.
  • Spirulina is a microalgae of the cyanobacteria. It has been found that the extract of the giant cyanobacteria in cyanobacteria has anti-leukemia activity, which has aroused people's interest in cyanobacteria.
  • Spirulina polysaccharide can significantly inhibit the growth of osteosarcoma cells in mice at the time of 200mg/kg, and inhibit the DNA of ascites hepatoma cells. And protein synthesis. Inhibition increased over time in 3-24 hours, and the semi-inhibition of different cancer cell lines was calculated and analyzed, indicating that different double cells have different sensitivities to spirulina polysaccharides. After the drug is removed from the culture medium, the rate of DNA synthesis in the cancer cells is rapidly restored. It is indicated that the inhibition of cancer cell proliferation by Spirulina polysaccharide is accomplished by inhibiting DNA synthesis, and this inhibition is a metabolic inhibition.
  • the recommended dosage of spirulina is 4.8g 60kg 1 d Kunming mice (secondary) and standing materials are provided by the Department of Laboratory Animal Science of Beijing Medical University. Animal qualified number medical word 01-3049.
  • the radiation was irradiated once, the dose rate was 3.21 Gy/miti, the irradiation time was 2 min 53 s, and the irradiation dose was 9 Gy.
  • Spirulina contains ⁇ -carotene, phycocyanin and polysaccharides five times as much as carrots.
  • the body's free radicals increase and damage cells cause cancer.
  • Beta-carotene is one of the most effective inhibitors of free radicals.
  • Algae proteins and algae polysaccharides have been recognized by the medical community at home and abroad to improve immune function and inhibit or kill tumor cells. At the same time, it has a definite effect on reducing the side effects of tumors after chemotherapy and radiotherapy. Resistance to radiation damage to human bone marrow cells has a strong anti-radiation effect.
  • the quinone-linolenic acid, vitamin strontium and superoxide dismutase (SOD) can enhance cell viability. In nature, Y-linolenic acid is only found in spirulina and breast milk.
  • Spirulina polysaccharide and polysaccharide protein can significantly reduce and improve the radiation rate and chromosome aberration types of Vicia faba root tip nuclei. It can significantly reduce the micronucleus rate of polychromatic red blood cells in the bone marrow of mice after irradiation, maintain the ratio of PEC/NCE in bone marrow cells, and significantly improve the leukopenia caused by radiation. Therefore, it is considered that Spirulina polysaccharide and polysaccharide protein are effective natural radiation protection agents.
  • Iodine and spirulina polysaccharides are the technical fields of two different disciplines. Spirulina alone cannot fight nuclear radiation. The WHO IAEA determined that effective iodine can resist nuclear radiation (spirulina polysaccharides are not identified as antinuclear radiation). On May 2, 1998, the Deep Star Times reported that Zhao Bofu iodine polysaccharide superhuman spirulina powder was certified by the Shenzhen Municipal Government (see attachment).
  • Spirulina polysaccharide is a biological macromolecule extracted from spirulina. It has anti-radiation and anti-mutation functions, can inhibit cell proliferation, and has swelling, gelation, water holding capacity and low heat which are very similar to dietary fiber. Value and other properties, which show a broad prospect for its application in functional health products.
  • Spirulina polysaccharide is an existing conventional biological extraction technology.
  • the available anti-cancer and anti-tumor bioactive substances are extracted by the modified trichloroacetic acid method.
  • the obtained product has a polysaccharide content of over 92%.
  • Spirulina polysaccharide has good medical and medicinal value.
  • the first anti-radiation and anti-aging effect, PSP can significantly enhance the DNA damage reactivation and extra-program DNA synthesis caused by radiation, and can delay the saturation of the above two important repair reactions and the ability of bone marrow cells to regenerate after irradiation, and promote the radiation damage of the hematopoietic system.
  • the recovery has certain anti-radiation and anti-chemical effects, has a killing inhibitory effect on cancer cells; secondly improves the body's immune function; third antiviral effect.
  • Existing products, an enterprise in Shenzhen sent algae to outer space through a spaceship, breeding "space spirulina tablets", “aerospace breeding” method to improve the content of spirulina polysaccharides, against weak electromagnetic radiation and chemotherapy It has certain effects, but it cannot effectively fight nuclear radiation "iodine-131" and is expensive.
  • there is a safe iodine "potassium iodide tablet” for anti-nuclear radiation which is limited to the use of nuclear energy crisis under certain conditions.
  • the World Health Organization International Atomic Energy Agency proposed the "Stable Iodine Prevention Strategy for Nuclear Energy Emergency Situations". Its stable iodine is inorganic iodine tablets (potassium iodide tablets and potassium iodate tablets), and it is not a "radiation antidote”. Not everyone. It can be taken only if it is clearly under the guidance of a public health agency.
  • the US FPA has set potassium iodide and potassium iodate as GRS grades. It is a low-toxic substance. It has been added salt for hundreds of years, and it has become the global must-have iodized salt of the world's "Iodine Supplement".
  • the WHO has announced that there are 650 million people worldwide with goiter, improper treatment, and papillary thyroid cancer is on the rise, and has spread in Central Africa, Southeast Asia, Central Asia, Central Europe, Eastern Europe and other regions.
  • inorganic iodine is a low-toxic substance, it has a dual nature, it can fight nuclear explosion, but it will cause different degrees of damage to the human body. How to replace inorganic iodine with organic iodine to counter nuclear explosion has become an urgent problem for our generation of scientists and technicians.
  • Mr. Zhao Bo made the spirulina powder rich in organic iodine polysaccharides into the algae polysaccharide extract by biotechnology more than ten years ago, added to soy sauce, monosodium glutamate and other foods, and added the phycoerythrin extract to Qingdao. In beer and Moutai, it caused a sensation in the food industry.
  • the World Health Organization's "safety iodine" (potassium iodide tablets and potassium iodate tablets) anti-radiation principle is "small poisonous attack and poison” method, taking more than iodine potassium iodide tablets and potassium iodate tablets, the thyroid is full, Resists radioactive iodine (131 iodine) to invade the body and prevent thyroid cancer. Its unfavorable factors and drawbacks, such as losing one, can not be prevented. Adopting this measure can reduce the incidence of "thyroid cancer", but it can not reduce the risk of thyroid enlargement and cancer change in the future. China Public Health, Vol. 22, No.
  • Mr. Zhao Bo used his own body to test and continuously took 5 years of high-dose organic iodine. His body's accumulated amount reached millions of micrograms, his urine iodine reached 7950 micrograms, and normal people's urine iodine was 200 micrograms, a world record. (For details, see the Jiangxi Provincial Health and Epidemic Prevention Station 98 urinary iodine test sheet.) If it is inorganic chemical iodine, it will definitely kill the organic iodine safety.
  • Spirulina polysaccharides and organic biological iodine can be formulated into a new generation of anti-nuclear radiation organic iodine tablets according to the standards set by the Ministry of Health, which provides technical support for replacing inorganic iodine tablets resistant to nuclear radiation. (See Example 5 for details)
  • SPP cerevisiae
  • CFU-S bone marrow hematopoietic stem cells
  • CFU-GM, CFU-E, BFU-E progenitor cells
  • mice Healthy Kunming mice, male and female, 8-10 weeks old, weighing 22-24g, were provided by the Experimental Animal Center of the Third Military Medical University. Irradiation condition 60Co Y 8Cy lethal dose, absorbent rate rate 46.75cGy / min, for hematopoietic stem cell colony determination, 5G main sublethal dose for detection of peripheral blood cells and granulocyte-monocytic hematopoietic progenitor cells, erythroid Experiments on the total number of hematopoietic progenitor cells and bone marrow nucleated cells.
  • SPP can promote the proliferation and differentiation of hematopoietic cells, participate in the direct or indirect regulation of hematopoietic progenitor cells and hematopoietic stem cells, and has an important impact on hematopoiesis and immune tissues. This effect may in turn be the main reason why SPP has anti-radiation effects and inhibits cell proliferation.
  • the explosion of the Chernobyl nuclear power plant in the former Soviet Union, the largest of Japan's relief supplies is the spirulina capsule containing polysaccharides. Pills and tablets.
  • the Center for Disease Control and Prevention of Jiangxi Republic concluded that the total iodine of "salt-rich spirulina for salt" (ie containing pure organic biological iodine) was 84,700 micrograms, and the mouse toxicology test report (finished on December 1, 2009) was served for 30 days. The three tests were all negative, mouse bone marrow polychromatic erythrocyte micronucleus test, mouse sperm abnormality test, AMES test. The main organ anatomy has no pathological changes and is actually non-toxic.
  • inorganic iodine (potassium iodate, potassium iodide) is between 10,000 ⁇ g and 10140 ⁇ g, the mice die after eating. It is fully proved that organic biological iodine safety is far superior to potassium iodide and potassium iodate.
  • the organic biological iodine is also called tyrosine iodine, wherein 1-iodotyrosine content is 96%, 2-iodotyrosine content is 2%, and sodium alginate is 2%.
  • the chemical structure of 1-iodotyrosine is:
  • the object of the present invention is to provide an anti-radiation spirulina polysaccharide organic biological iodine, which prevents and prevents the micro-nuclear radiation generated in the surrounding areas after a nuclear energy crisis or a nuclear energy accident has occurred.
  • the product prepared by the invention has the function of preventing and preventing the micro-nuclear radiation, and can effectively resist the radiation of the human body caused by various types of mobile phones, computers and home appliances and after chemotherapy, and achieve anti-fatigue, anti-virus, anti-cancer, and improve Human immune function, effective iodine supplementation, without any side effects, improve human health;
  • the present invention provides superior human immunity against nuclear radiation and various types of radiation in the event of a nuclear accident and a nuclear accident.
  • Technical "stability The control effect of iodine (ie potassium iodide tablets and potassium iodate tablets), its anti-radiation principle is "toxin-free and poisonous", which is novel and creative. It benefits human health.
  • the present invention is implemented in this way:
  • Providing a spirulina polysaccharide organic biological iodine characterized in that fresh living algae is used as a carrier, spirulina polysaccharide and organic biological iodine are added, and optical autotrophic biological reaction occurs under illumination and temperature control to obtain spirulina polysaccharide organic biological iodine .
  • the organic biological iodine of the spirulina polysaccharide described above is preferably 50-96% by weight of algae, 3-50% of spirulina polysaccharide, and 0.0001%% of organic biological iodine.
  • the spirulina polysaccharide organic biological iodine described above is characterized in that the fresh living algae is selected from the group consisting of Spirulina platensis, giant spirulina or chlorella.
  • the spirulina polysaccharide organic biological iodine described above is characterized in that the organic biological iodine is composed of 96% 1-iodotyrosine, 2% 2-iodotyrosine and 2% sodium alginate.
  • the spirulina polysaccharide organic biological iodine described above is characterized in that the illumination is sunlight or an artificial light source, and the illumination intensity is 5 to 100 lux, and the wavelength is 400 to 700 nm.
  • the spirulina polysaccharide organic biological iodine described above is characterized in that the temperature control is between 30 ° C and 4 (TC).
  • the spirulina polysaccharide organic biological iodine described above is characterized in that, based on the dry powder of the algae mud, 3 to 50 g of spirulina polysaccharide is added per 100 g of dry powder of algae mud, and the organic biological iodine is calculated as 100-10,000,000 micrograms of iodine. .
  • the present invention also provides the use of the above-mentioned spirulina polysaccharide organic biological iodine in the preparation of a medicine or health food for use in anti-radiation, anti-immunity, anti-cancer or anti-virus.
  • the radiation is ionizing radiation and nuclear micro-radiation or nuclear energy radiation.
  • the spirulina polysaccharide of the present invention can be prepared by the spirulina polysaccharide preparation technology known in the prior art. To. E.g:
  • spirulina polysaccharide polysaccharide ⁇ Spirulina. PS
  • the spirulina dry powder is first broken, and the lipophilic component is removed with a low-polar solvent, and extracted by hot water or lye. Microwave-assisted extraction), the supernatant was concentrated, ethanol was alcohol-decomposed, centrifuged, and dried to obtain crude polysaccharide of Spirulina.
  • the protein in spirulina accounts for about 60 ⁇ 70% of the dry weight of the cells, so the key to extracting spirulina polysaccharide is to effectively remove the protein.
  • Sevag method Sevag method
  • foam separation technique trichloroacetic acid (TCA) method
  • heating concentration method enzymatic method.
  • the Sevag method is a classic method of deproteinization and is usually only applied to a small amount of protein and must be repeated multiple times.
  • Deproteinization by TCA can shorten the process and reduce the loss rate of polysaccharides, which is conducive to subsequent purification.
  • Enzymatic degradation of proteins increases the yield of crude polysaccharides, but there are still more than 30% of the protein in the resulting ingredients.
  • the polysaccharide extraction process was carried out by a double enzyme method (trypsin, papain), and the residual protein content was determined to be 3%.
  • the crude polysaccharide obtained by extracting with aqueous extract may contain a plurality of mixed sugar components and small molecular impurities, and further fractionation and purification is required to obtain a single pure product of spirulina polysaccharide.
  • a single narrow peak is generally observed after chromatography as a criterion for purity determination.
  • Commonly used purification methods are:
  • Ion exchange cellulose chromatography ion exchange and cellulose chromatography are combined to form a series of ion exchange cellulose chromatography. Based on the affinity of the resin for different ions, various polysaccharides are dissolved to separate the sugars. In the separation process, a gradient of NaCl solution or phosphate buffer solution is often used to obtain a single component of different fractions. Common are DEAE cellulose, and DEAE-Sepharose.
  • the gel filtration method is a chromatography method using a gel particle having a certain pore size as a support, and is capable of separating molecules having different sizes and shapes, and is particularly effective for separating sugars having different polymerization degrees.
  • Sephadex G, Sepharase, and Bio-gel P are all hydrophilic gels, which are widely used in the purification of polysaccharides.
  • Sephadex G100 or Sephadex G200, Sepharyl S 100 are generally used in the purification of spirulina polysaccharides.
  • Sephadex G itself is a sugar, and it is inevitable that the eluate will be contaminated with sugar eluted from the gel, which may cause impureness of the refined polysaccharide.
  • the content of the polysaccharide after purification was determined by the guanidinone sulfate method.
  • the invention also provides a more efficient new process for extracting polysaccharides from spirulina. That is, the polysaccharide extraction process was carried out by double enzymatic method (trypsin, papain), and the deproteinization effect was close to 100%.
  • the crude polysaccharide was further purified by ion exchange chromatography and gel chromatography, and its composition was determined by paper chromatography.
  • the crude polysaccharide was purified by DEAE-Sep harose and Sep hadex-G50 to obtain 2 polysaccharide fractions.
  • the monosaccharide composition of component 1 is determined to be D _glucose, D-xylose, D-galactose, glucuronic acid; the monosaccharide composition of component 2 is: D-glucose, D-mannose, L-rhamnose, D-galactose, glucuronic acid.
  • the protein was determined by the Kay-style nitrogen method.
  • the optimal temperature of trypsin was determined.
  • the optimum temperature for trypsin was 55 V. At this time, the enzyme was the best.
  • Trypsin has a high enzyme activity in the range of 6.2 to 7.2.
  • the trypsin hydrolysis time was determined. After 2.5 h of trypsin treatment, the protein content in the crude polysaccharide product no longer decreased significantly. Therefore, the reaction could be stopped after 2.5 h of protease action.
  • the optimum amount of trypsin was determined. After the enzyme dosage reached 3.0%, the deproteinization effect was no longer significantly increased, so the enzyme dosage was determined to be 3.0%.
  • Polysaccharide separation was carried out using a DEAE-Sepharose column (20 X lcm): The ion exchange column was equilibrated with 0.01 mol/L, p H8.0 in pyridine-hydrochloric acid buffer. The crude polysaccharide was loaded at 8 mL and the flow rate was 25 mL/h. The gradient was eluted with O.Olmol / L, pH 8.0 in pyridine-hydrochloric acid buffer and 0 to 2 mol/L NaCl to obtain the curve shown in Fig. 1. The two peaks of the curve were separately collected and lyophilized to obtain a crude component 1 and a crude component 2.
  • the Sephadex-G50 gel column (90 X2 cm) was used to separate the crude polysaccharide component 1 and the polysaccharide crude component 2, and the eluent was distilled water at a flow rate of 25 mL/h, and the curves shown in Fig. 2 and Fig. 3 were obtained. A single solution was separately collected, and after freeze-drying, the pure component 1 and the pure component 2 of the polysaccharide were obtained.
  • the polysaccharide sample is subjected to acid hydrolysis and paper chromatography to obtain a monosaccharide composition: component 1 is D-glucose, D-xylose, D-galactose, glucuronic acid; component 2 is D-glucose, D-mannose, L-rhamnose, D-galactose, glucuronic acid.
  • the spirulina polysaccharide organic biological iodine of the invention can be used as edible and medical, and can produce anti-radiation spirulina polysaccharide organic biological iodine tablets, capsules, granule pills, powder granules, oral liquid, titration liquid and the like.
  • the organic iodine content of the anti-nuclear radiation product of the present invention is added according to the latest specified standard of the Ministry of Health of the People's Republic of China, wherein 25 mg (ie 25,000 micrograms) for children under 3 years old, 100 mg (ie 100,000 micrograms) for adults, maternal and 3 50 mg (ie 50,000 micrograms) for children -12 years old; 100 mg for one adult food equivalent to the total iodine content of five kilograms of iodized salt.
  • the existing drug microcapsule production technology and the existing iodized oil pill production technology can be employed.
  • the walnut oil and soybean oil in the original iodized oil pills are deleted, and the use of olive oil (the high content of unsaturated fatty acids) is beneficial to the heart and blood vessels, which can achieve the purpose of slowly absorbing effective iodine. Seek more effective and safe against radiation iodine.
  • the above-mentioned disposable consumption can be formulated into 2-3 doses instead of the sustained release agent.
  • the anti-nuclear micro-radiation, anti-ionizing radiation and chemotherapy products contain 3-12g of natural spirulina polysaccharides, and the organic iodine content versatile product is formulated at 5 micrograms per gram, which is suitable for any population.
  • the spirulina polysaccharide content is 12-50g.
  • the spirulina polysaccharide organic biological iodine of the invention can be used as a therapeutic health food for anti-nuclear micro-radiation, anti-ionizing radiation and chemotherapy, and to improve human immunity and anti-cancer and anti-virus functions.
  • the spirulina polysaccharide organic biological iodine of the invention can be used as a medicine for preventing nuclear radiation radiation prevention and treatment, rescuing the victims, reducing the incidence of cancer and improving the human immunity, and is superior to the prior art "stable iodine" (ie, potassium iodide) And the effect of the prevention and treatment of potassium iodate tablets for the benefit of human health.
  • stable iodine ie, potassium iodide
  • the spirulina polysaccharide organic biological iodine of the invention is tested according to the acute toxicity test of mice, "Superman spirulina powder" (Iodine-rich polysaccharide type) (98) Guangdong Weifang anti-drug test word No. A022 report, is a non-toxic substance and Shandong Provincial Qingdao Municipal Center for Disease Control 2003CT00019 "Preliminary Stability Test for Edible Sodium Spirulina" report, certified by the National Science and Technology Commission, Light Science and Characters [199] No. 014, scientific and technological achievements identification, the results identified as adding salt and other It is an innovation and is a safe food for iodine supplementation. Organic iodized salt has been sold for 11 years, and there is no toxic side effect, which is well received by users.
  • Figure 2 Sephadex - G50 column elution curve for polysaccharide fraction 1;
  • Figure 3 Sephadex - G50 column elution curve for polysaccharide fraction 2.
  • Example 1 Anti-nuclear micro-radiation, anti-home appliances, communication, chemotherapy ionizing radiation, spirulina polysaccharide organic organisms iodine preparation method:
  • the ratio of the formula is: the algae mud is spray dried every 10-15 kg or After lyophilization, it can be made into 1 kg of dry algae powder, and 30-500 g of spirulina polysaccharide is added per 10-15 kg of algae mud, while pure organic biological iodine powder is added, lg contains 1-5 micrograms ⁇ stir evenly ⁇ in daylight or Artificial light source (light intensity 5-10 million lux, wavelength 400-700 nm) temperature control between 30 ° C and 40 ° C ⁇ optical autotrophic biological reaction ⁇ spray drying or freeze drying into spirulina dry powder, measured The total iodine content of organic iodine is 100-500 micrograms per 100 grams, and the dry algae powder spirulina polysaccharide is 3-50 grams per 100 grams, which is qualified product ⁇ finished product packaging ⁇ storage at 15 ° C
  • the above products are anti-nuclear micro-radiation, anti-cell phone, computer, home appliance, and post-chemotherapy radiation (this product is suitable for any group of people, regardless of age and gender).
  • Example 2 Anti-nuclear micro-radiation, anti-home appliance, communication, chemotherapy ionizing radiation, spirulina polysaccharide organic biological iodine preparation method (addition of iodine type, see the instructions for different age groups):
  • the ratio of the formula is: the algae mud is spray dried every 10-15 kg or After lyophilization, it can be made into 1 kg of dry algae powder, and 30-500 g of spirulina polysaccharide is added per 10-15 kg of algae mud, and pure organic biological iodine powder lg is added after 20-50 micrograms ⁇ stirring evenly ⁇ in daylight or Artificial light source (light intensity 5-10 million lux, wavelength 400-700 nm) temperature control between 30 ° C -40 ° C ⁇ optical autotrophic biological reaction ⁇ spray drying or freeze drying into spirulina dry powder, measured The total iodine content of organic iodine is 2000-5000 micrograms per 100 grams, and the dry algae powder spirulina polysaccharide is 3-50 grams per 100 grams, which is qualified product ⁇ finished product packaging ⁇ storage at 15 ° C -20
  • the formula ratio of the ingredients is lyophilized after every 10-15 kg It can be made into 1 kilogram of spirulina dry powder, and pure organic biological iodine powder is added every 10-15 kg of algae mud, so that the end product can reach adult (100,000 micrograms of organic iodine per gram of dry algae powder) or maternal and 3- 12-year-old children (containing 50,000 micrograms of organic iodine per gram of dry algae powder), or children under 3 years old (containing 25,000 micrograms of organic iodine per gram of dry algae powder), and adding 300-500 grams per 10-15 kg of algae mud After the spirulina polysaccharide ⁇ stir evenly, in the daylight or artificial light source (light intensity 5-10 million lux, wavelength 400-700 nm) temperature control between 30 ° C -40 ° C ⁇ optical autotrophic biological
  • Example 4 Preparation method of organic biological iodine for anti-nuclear radiation spirulina polysaccharide:
  • the formula ratio of the ingredients can be lyophilized after every 10-15 kg Into 1 kg of spirulina dry powder, add pure organic biological iodine powder per 10-15 kg of algae mud, so that the end products can reach adults (100,000 micrograms of organic iodine per dry algae powder) or maternal and 3-12 years old Children (containing 50,000 micrograms of organic iodine per gram of dry algae powder), children under 3 years old (containing 25,000 micrograms of organic iodine per gram of dry algae powder), and adding 300-500 grams of spirulina polysaccharide per 10-15 kg of algae After ⁇ stirring evenly, in daylight or artificial light source (light intensity 5-10 million lux, wavelength
  • Example 5 Anti-radiation spirulina polysaccharide organic biological iodine effect test:
  • Zhao Bo took more than 40% of the iodine content test report (for reference only)
  • 75 75 is normal, the same as the same, the same as above, the knot, the abacus, the morning, often drink more often
  • the total amount of experiments taken for six consecutive days is 54000 micrograms, which is in line with the maternal and 3-12 year old children of the Ministry of Health (containing 50,000 micrograms of organic iodine per gram of dry algae powder), and children under 3 years old (2.5 grams per gram of dry algae powder) 10,000 micrograms of organic iodine) standard, this case has played a role in replacing the slow release agent.
  • Example 6 Iodine-rich spirulina powder for salt (high dose group) Anti-radiation organic iodine interpretation:
  • Acute oral toxicity test Acute oral toxicity of male and female mice with iodine-rich spirulina powder is greater than MTD
  • mouse bone marrow polychromatic erythrocyte micronucleus test mouse bone marrow polychromatic erythrocyte micronucleus test results were negative.
  • Mouse sperm abnormality test The test result of mouse sperm abnormality is negative.
  • Ames test Ames test results are negative.
  • Rat 30-day feeding test There was no significant difference in body weight, food utilization rate, and main body ratio between the animals in each dose group (P>0.05).
  • White blood cell count and its classification, red blood cell count, hemoglobin and various biochemical indicators in the control group and each dose group is within the normal reference range of the laboratory.
  • the daily consumption of each mouse was 84,700 micrograms, which was taken continuously for 30 days, for a total of 2541,000 micrograms. No significant pathological changes were observed in the gross anatomy of the animals and the pathological examination of the main organs. No poisoning occurred and no lesions occurred. It can be inferred that it is safe for an adult to take 100,000 micrograms per time. This dose can be used to meet the standard amount of anti-nuclear explosion in adults, pregnant women and children in the Ministry of Health.
  • mice Effect of Spirulina platensis polysaccharide on the number of peripheral blood cells and bone marrow nucleated cells in mice (X s s) index post-injury time normal control group normal medication group radiation control group radiation damage
  • Example 9 Effect of anti-radiation of Spirulina platensis polysaccharide on NK cells in patients with acute leukemia
  • SPP increased the peripheral blood sputum cell activity of 31 leukemia patients from 26.41 ⁇ 10.17% to 38.33 + 9.45% ( ⁇ ⁇ 0 ⁇ ), but still lower than normal human NK cell activity ( ⁇ ⁇ 0.01), peripheral phase of acute leukemia patients with different stages
  • the activity of sputum cells was significantly increased after blood mononuclear cells were added to SPP ( ⁇ 0.01).
  • the sputum cell activity and SPP increased in the initial and recurrent patients, it was still lower than that in normal subjects ( ⁇ 0.01), but there was no significant difference between the sputum cell activity and SPP in the remission phase compared with normal subjects ( ⁇ > 0.05), see attached table.
  • Example 10 Spirulina polysaccharides against ultraviolet radiation
  • the optimal concentration of the drug-administered group the cells were cultured in 96 empty plates, and the cells in each drug concentration group were different in growth compared with the control group, and the cells in the 1600 and 800 g 'L- 1 dose groups were On the 2nd day after inoculation, the cells were rounded and difficult to adhere to the wall. On the third day, the cell residue in the culture solution was observed. The drug dose group was counted on the 4th day after inoculation. The results are shown in Table 1, thereby determining the dose of PSP. 100, 50, 25 g ⁇ L- Table 1 Effect of different PSP concentrations on cell growth (Xis) ⁇
  • the cells were seeded at a density of 1 ⁇ 10 6 /cm 2 in a 25 mL culture flask, still containing 10% fetal calf serum, 0.3% L-glutamine, 100 U ⁇ ⁇ 1 Penicillin and lOOmg ⁇ L 1 streptomycin were cultured, and the control group and the PSP administration group of 100, 50, 25 mg - L" 1 were separately cultured, and the cells were irradiated for 30 minutes under UV for 4 minutes. Laying, denaturation, unwinding, electrophoresis, neutralization, staining, observation and filming, and randomly selecting 10 cells on each slide to measure the DNA migration distance (MLD) of the control group and each drug group. Table 2, MLD of each drug-administered group was significantly reduced compared with the control group, and there was significant difference in statistics.
  • MLD DNA migration distance
  • PSP was cultured after basal level injury, and SCGE was performed at 30, 60, and 90 min after injury.
  • the MLD of each group of cells and time was as shown in Table 3, Figure 4.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明提供一种螺旋藻多糖有机生物碘及其应用。以新鲜活体藻泥为载体,加入螺旋藻多糖和有机生物碘,在光照和温控下发生光学自养生物反应而得到螺旋藻多糖有机生物碘,可用于制备抗电离及核微量辐射或核能辐射、提高人体免疫力、抗癌或抗病毒的药品或保健食品。

Description

说 明 书 抗辐射螺旋藻多糖有机生物碘及其应用
技术领域
本发明涉及到一种抗辐射螺旋藻多糖有机生物碘及其应用。 背景技术 英国科学家贝弗里曾预言 "威胁人类两大隐形杀手是辐射及疲劳过度", 人类处 在手机、 冰箱、 电视、 电脑、 日光灯、 微波炉、 电磁波、 空调、 吸尘器等通讯家电不 同程度电磁辐射范围中, 加上大自然中产生的辐射, 时间长久后, 造成大脑伤害, 引 起疲劳、 耳鸣、 眼疾、 头痛脑胀等症状。
《世卫组织称长期用手机可能致癌 建议青少年慎用》
来源: 中国新闻网 2011年 06月 01 日 15:25
中新网 6月 1 日电世界卫生组织下属的国际癌症研究中心联合发表报告称,一些 癌症 (特别是神经胶质瘤)与手机可能有联系, 而神经胶质瘤是脑癌的一种。
奥巴马总统国家癌症顾问委员会成员萨米特( Jonathan Samet)在声明中说: "可能 有风险, 我们需要对手机和癌症的联系进行进一步的观察。 "
在使用手机时, 辐射出的电磁波会加热人体组织, 并造成伤害。
世界卫生组织和多国政府都特别强调的是, 青少年应该慎用手机。 青少年的耳朵和颅 骨比成年人更小、 更薄, 他们在使用手机时, 脑部吸收的辐射比成年人要高出 50%。
86年 4月 26日, 前苏联切尔诺贝利核电站爆炸。 1979年, 美国三哩岛核电站事 故。 2011年 3月 11 日大地震引发日本福岛核电站爆炸, 波及全球。 核爆将放射性物 质释放到大气中, 形成放射性羽流, 随着气流漂移; 放射性物质冷却用水被排到海洋 中, 附近国家蔬菜及自来水已检测出有微量放射物质, 微量核辐射 100微西弗对人体 健康影响到目前为止很难给出定论。核辐射专家邓普言"发病率与辐射量呈线性关系, 一直延伸到低剂量范围。" 2008年德国核电站在 《欧洲癌症学报》 披露, 生活在核电 厂周围 5000米范围内, 5岁以下儿童患癌病率上升 47%。新华社电讯报道, 专家认为 30 年后, 福岛放射物将扩散至整个太平洋。 另一个核能专家布伦纳认为 "辐射破坏 DNA, 而那怕是一个受损细胞, 都可能成为癌症种子, 癌症的发展可以历时数十年。" 微量核辐射对人类健康是缓慢 10年乃至 20年致癌, 未爆发出来前是一个长期潜伏不 可疏忽的隐形杀手。
核爆放射物 131-碘被媒体报道后, 不少人误以为用无机碘可对抗核爆, 在国内引 发抢购碘盐风潮 (实际上 5公斤碘盐总碘含量一次性服用才能对抗核爆 131-碘), 人 类对核能爆炸产生恐惧。 "潘多拉魔盒"现象发生了, 核能发电造福人类同时, 又 给人类带来灾难。
《螺旋藻抗辐射抗癌功效及原理 (一)》
摘自螺旋藻抗辐射抗癌功效及原理 (一) 百度文库
螺旋藻的抗辐射、 抗诱变、 防癌、 抗癌作用也已为人们发现, 本文对螺旋藻研究 作一简要综合。
研究资料表明螺旋藻具有很强的抗辐射和抗诱变性, 用不同弧度的辐射线照射螺 旋藻, 在照射强度达 lOOGy(lOOk rad)时, 都未观察到对螺旋藻生长的抑制作用, 说明 螺旋藻具有很强的辐射抗性。
螺旋藻属蓝藻类的微藻, 很早前就有人发现蓝藻中巨大鞘丝藻的提取物具有抗白 血病活性, 从而激起了人们对蓝藻的研究兴趣。
刘力生等 (1991 ) 作了用螺旋藻多糖对移植性癌细胞抑制作用的研究, 螺旋藻多 糖在 200mg/kg剂最时可以显著抑制小鼠体内骨肉瘤细胞的增豉, 抑制腹水型肝癌细 胞 DNA和蛋白质的合成。 抑制作用在 3-24小时内随时间的延长而提高, 通过对不同 的癌细胞株的半抑制量计算分析, 说明不同的双细胞对螺旋藻多糖的敏感性不一样。 将药物从培养基中撤除以后, 癌细胞 DNA合成的速度迅速恢复。 说明螺旋藻多糖对 癌细胞增殖的抑制是通过抑制 DNA合成所完成, 而且这种抑制是属于代谢抑制。
《螺旋藻抗辐射作用研究》崔文明, 张馨, 刘泽钦, 李宁, 韩驰 (中国预防医学 科学院营养与食品卫生研究所, 北京 100050)
本实验以血白细胞计数、 30d小鼠存活率、 小鼠骨髓细胞微核率和小鼠生殖细胞 染色体畸变率为观察指标, 对螺旋藻的抗辐射保健作用进行了研究。
螺旋藻人体推荐用量为 4.8g 60kg 1 d 昆明种小鼠 (二级) 和常备伺料由北京 医科大学实验动物科学部提供。 动物合格号医动字 01-3049。
射线辐照 1次, 辐照条件剂量率为 3.21 Gy/miti, 辐射时间为 2min 53s, 照射剂量 为 9Gy。
结果表明螺旋藻对多次辐照所引起的小鼠染色体损伤有保护作用, 并呈较好的剂 量 -反应关系。
结果表明螺旋藻对亚慢性辐照所引起的生殖细胞染色体损伤有保护作用。
《螺旋藻抗辐射作用》 (齐国力 北京大学生物医学研究所教授、 北京医科大学 附属医院内科主任、 美国医学会会员, 发表于 2003年 3月 21 日 《解放日报》)
螺旋藻抗辐射机理
螺旋藻中含有 5倍于胡萝卜的 β -胡萝卜素、 藻蓝蛋白与多糖类物质。 人体自由 基增多而损伤细胞导致癌症, β -胡萝卜素是最有效抑制自由基活性物质之一。 藻类 蛋白、 藻类多糖已为国内外医学界公认有提高免疫功能, 抑制或杀伤肿瘤细胞有着肯 定的疗效。 同时对减轻肿瘤在化疗、 放疗后的副作用升高白细胞均有确切效果。 抵抗 射线对人体骨髓细胞的损害, 具有较强的抗辐射作用。而含有的 Υ -亚麻酸、维生素 Ε 和过氧化物歧化酶 (SOD ) 能增强细胞活力。 而在自然界中, Y -亚麻酸仅在螺旋藻 和母乳中才含有。
阮继红的研究显示, 螺旋藻多糖和多糖蛋白, 能显著减轻和改善辐射引起的蚕豆 根尖细胞核的畸变率和染色体畸变类型。 能明显减少辐射后小鼠骨髓中嗜多染性红细 胞的微核率, 维持骨髓细胞 PEC/ NCE的比率, 并对辐射引起的白细胞减少有明显的 改善作用。 因而认为, 螺旋藻多糖及多糖蛋白, 是一种有效天然辐射防护剂。
碘元素与螺旋藻多糖是两种不同学科的技术领域, 单靠螺旋藻多糖不能对抗核辐 射, 世卫组织原子能机构认定, 有效碘才能抗核辐射 (螺旋藻多糖没有被认定抗核辐 射) 。 98年 5月 2 日深星时报报道赵波富碘多糖超人螺旋藻粉通过深圳市政府鉴定 (见附件) 。 人民日报 98年 6月 29 日科技天地栏目第十五版报道了深圳市政府及 科技局鉴定结论: 超人螺旋藻富碘多糖耐高温、 无藻腥, 引起国内外科技界的巨大反 响。 有机碘与螺旋藻多糖有机结合添加到食品中是一项创新, 填补了国内外空白。 螺旋藻多糖是从螺旋藻中提取的一种生物大分子, 具有抗辐射、 抗突变的功能, 可抑制细胞增殖, 并具有与膳食纤维极为相似的膨胀作用、 凝胶作用、 持水能力、 低 热值等性质, 这为其在功能性保健品中的应用展示了广阔的前景。
螺旋藻多糖 (PSP) 是一种现有的常规生物提取技术, 可获得的抗癌抗肿瘤的生 物活性物质, 以改良的三氯乙酸法进行提取, 所得产品多糖质量含量达 92%以上, 优 于传统的 SEVDG法。螺旋藻多糖具有很好的医用药用价值。第一抗辐射抗衰老作用, PSP能显著增强辐射引起 DNA损伤复活和程序外 DNA合成,而且能延缓以上两个重 要修复反应的饱和及遭受辐射后动物骨髓细胞再生能力, 促进造血系统受辐射损伤的 恢复, 具有一定抗辐射和抗化学物质作用, 具有对癌细胞的杀伤抑制作用; 第二提高 人体免疫功能; 第三抗病毒作用。 因螺旋藻多糖价格昂贵, 我国医学界主要仅限用于 抗癌抗肿瘤上。现有产品,深圳市某企业将藻种通过宇宙飞船送到外太空,育种出 "太 空螺旋藻片", "航天育种"方法提高螺旋藻多糖含量, 对抗弱电磁辐射及化疗具有 一定功效, 但不能有效对抗核辐射"碘 -131 ", 且成本昂贵。 目前现有技术有种抗核辐 射的安全碘 "碘化钾片" 限止在特定条件下发生核能危机时使用。
世界卫生组织国际原子能机构提出了 《核能应急情况下稳定碘预防策略》, 其稳 定碘实为无机碘片 (碘化钾片及碘酸钾片), 并公布不是 "辐射解毒剂" 也不是所有 人都能服用, 只有在公共卫生机构明确指导下才需要才能够服用。
美国 FPA把碘化钾及碘酸钾定为 GRS级, 属低毒物质, 添加食盐已上百年, 成 为当今世界 "补碘"专营的全球必食之碘盐。
世卫组织公布目前全球有 6.5亿人口甲状腺肿, 治疗不当, 患乳头状甲状腺癌呈 上升趋势, 已在中非、 东南亚、 中亚、 中欧、 东欧等地区泛滥。
江南都市报 2010年 4月 23 日 《我们的盐吃得太多了》浙江医院一年收 205名甲 状腺癌病人, 比 10年前增长了 10倍。 均由于无机碘盐所造成。
国内外军方防化部队在对抗生化武器及细菌战时都备有高浓縮的有效碘片(碘酸 钾片及碘化钾片)。
鉴于无机碘属低毒物质, 它具有双重性, 它能对抗核爆, 但又对人体会造成不同 程度的伤害。如何用有机碘替代无机碘对抗核爆就成了我们这一代科技工作者急需解 决的难题。
赵波先生在十几年前就将富含有机碘多糖的螺旋藻粉通过生物技术制成了藻兰 多糖提取液, 添加到酱油、 味精等食品中, 并将藻兰多糖提取液添加到青岛啤酒和茅 台酒中, 引起食品界轰动。
世界卫生组织的 "安全碘" (碘化钾片及碘酸钾片) 抗辐射原理是 "以小毒攻大 毒"方法,服用超过量碘的碘化钾片及碘酸钾片后,使甲状腺充满,可抵制放射碘(131 碘) 侵入人体, 防止甲状腺癌发生。 其不利因素和弊端, 顾此失彼, 防不胜防。 采用 此举, 相对可减少 "甲状腺癌"发病率, 但不能减少今后引发甲状腺肿大中毒及癌变 化风险。 中国公共卫生 2006年 4月第 22卷第 4期《碘过量对机体危害及有机碘的开 发利用》 已有报道, 另有研究发现, 无机碘摄入超过 40μ§/(1, 180d后小鼠甲状腺明显 肿大, 而海带有机碘摄入量即使超过 200μ§/(1, 小鼠甲状腺也未见明显肿大, 同时还 发现海带有机碘可防治高碘甲肿。
中国公共卫生 2007年 4月第 23卷第 4期 《碘对人甲状腺细胞增殖影响》 报道, 我国甲状腺疾病的发病率呈现上升期不同浓度有趋势, 过多的无机碘能够抑制甲状腺 细胞的增殖, 损害甲状腺细胞, 而有机碘对甲状腺细胞增殖情况的影响报道较少。 本 文利用体外碘刺激试验测定不同浓度的有机碘和无机碘对甲状腺细胞增殖情况的影 响, 探讨有机碘对人甲状腺细胞的影响, 为其作为一种安全的补碘制剂提供依据。
赵波先生用自己人体做试验, 连续服用 5年高剂量的有机碘, 体内积存量达到数 百万微克, 其尿碘已达 7950微克, 正常人的尿碘是 200微克, 创世界纪录。 (详见江 西省卫生防疫站 98年尿碘化验单) 若是无机化学碘, 必死无疑, 反证了有机碘对人 体的安全。 用螺旋藻多糖及有机生物碘按国家卫生部规定标准, 可配制成新一代抗核 辐射有机碘片, 取代抗核辐射的无机碘片提供技术支撑。 (详见实施例五)
《重庆医学》 2003年 03期登载 《钝顶螺旋藻多糖对辐射所致小鼠造血功能抑制 的对抗影响》 临床试验, 由西藏军区总医院皮肤科、 第三军医大学预防医学系防原医 学教研室及大坪医院血液内科、 南京大学生物系联合共同试验结果证明: 螺旋藻多糖 可对抗核辐射。 本实验运用造血细胞培养技术, 选用钝顶藻多糖 (SPP ), 较系统地 观察了 SPP 对正常小鼠和 6QCO Y射线 5Gy 照射小鼠外周备细胞, 骨髓造血干细胞 ( CFU-S ) 和造血祖细胞 (CFU-GM、 CFU-E、 BFU-E ) 增殖分化的影响及其作用特 点, 拟在研究螺旋藻多糖对机体造血功能的调控作用。
健康昆明种小鼠, 雌雄各半, 鼠龄 8-10周, 体重 22-24g, 由第三军医大学实验 动物中心提供。照射条件 60Co Y 8Cy致死量照射, 吸收剂率率 46.75cGy/min, 用于 造血干细胞集落测定, 5G主亚致死量照射用于检测外周血各类细胞及粒 -单系造血祖 细胞、 红系造血祖细胞和骨髓有核细胞总数的实验。
结果: 钝顶螺旋藻多糖对外周血细胞及骨骼有核细胞数的影响伤后小鼠外周血 WBC、 PLT及 BMC均较正常对照组明显降低(P<0.01 ),辐射用药组小鼠 WBC、 BMC 又明显高于辐射对照组, 而 Hb、 PLT数帽无明显改变 (P>0.05 )。 表 1显示正常用药 组小鼠 BMC明显高于正常对照组 (P<0.01 ), 而其它指标与正常对照组相比, 均无显 著性差异 ( P>0.05 )。
详见附件: 表 1 钝顶螺旋藻多糖对小鼠外周血细胞及骨髓有核细胞数的影响(X ± s), 表 2 钝顶螺旋藻多糖对小鼠造血祖细胞及造血干细胞数的影响 (x ± s)。
SPP能促进造血细胞的增殖与分化, 参与造血祖细胞和造血干细胞的直接或间接 的调控活动, 并对造血和免疫组织有重要影响。这种影响又可能是 SPP具有抗辐射作 用和抑制细胞增殖的主要原因。 前苏联切尔诺贝利核电站爆炸, 日本救灾物资中最多的就是含多糖的螺旋藻胶囊 丸及片剂。
江西疾病预防控制中心对 "盐用富碘螺旋藻"(即含纯有机生物碘)总碘在 84700 微克, 老鼠毒理实验报告 (2009年 12月 1 日完检)连服 30天后的结论, 其三致试验 均属阴性, 小鼠骨髓嗜多染红细胞微核试验, 小鼠精子畸形试验, AMES试验。 主要 脏器解剖无病理变化, 属实际无毒。 (经检索查新, 国内外无此案例) 而无机碘 (碘 酸钾、 碘化钾)在 10000微克 -10140微克时, 老鼠食后即亡。 充分证明有机生物碘安 全性远远优于碘化钾、 碘酸钾。
有机生物碘又叫酪氨酸碘, 其中 1-碘酪氨酸含量 96%、 2-碘酪氨酸含量 2%、 海 藻酸钠 2 %。 其中 1-碘酪氨酸化学结构式为:
Figure imgf000008_0001
CH C¾ '··'、;>—— OH
C顯 I 、 有机生物碘及其优点在 《有机生物碘及其应用》 (专利号: ZL200310111222.2 , 专利权人: 赵波) 中已作阐述。 发明内容
本发明的目的就是提供一种抗辐射螺旋藻多糖有机生物碘, 在未发生核能危机之 时或已发生核能事故后的周边地区所产生的微量核辐射的防范和预防。使用本发明配 制的产品对微量核辐射有防范和预防作用外, 可有效对抗防治各类手机、 电脑及家电 产品及化疗后造成对人体的辐射, 达到抗疲劳, 抗病毒, 抗癌变, 提高人体免疫功能, 有效补碘, 无任何毒副作用, 提高人类健康素质; 本发明在即将发生核能事故和已发 生核能事故之时为人类有效对抗核辐射及各类不同辐射, 提供了优于现有技术 "稳定 碘"(即碘化钾片和碘酸钾片) 的防治效果, 其抗辐射原理是 "以无毒攻大毒", 具有 新颖性、 创造性。 造福于人类健康。
本发明是这样来实现的:
提供一种螺旋藻多糖有机生物碘, 其特征在于以新鲜活体藻泥为载体, 加入螺旋 藻多糖和有机生物碘, 在光照和温控下发生光学自养生物反应而得到螺旋藻多糖有机 生物碘。
其中, 上述所述的螺旋藻多糖有机生物碘, 按重量配比, 优选为藻泥占 50-96%, 螺旋藻多糖占 3-50%, 有机生物碘占 0.0001-10%。
上述所述的螺旋藻多糖有机生物碘, 其特征在于所述的新鲜活体藻泥选自钝顶螺 旋藻、 巨大螺旋藻或小球藻。
上述所述的螺旋藻多糖有机生物碘, 其特征在于所述的有机生物碘由 96 %的 1- 碘酪氨酸、 2 %的 2-碘酪氨酸和 2 %的海藻酸钠组成。
上述所述的螺旋藻多糖有机生物碘, 其特征在于所述的光照为日光或人造光源, 其光照强度 5-10万勒克司, 波长 400-700毫微米。
上述所述的螺旋藻多糖有机生物碘, 其特征在于所述的温控是温度在 30°C -4(TC 之间。
上述所述的螺旋藻多糖有机生物碘, 其特征在于以藻泥的干粉计算, 每 100g藻 泥干粉, 加入螺旋藻多糖 3-50克, 有机生物碘以碘计算 100-10,000,000微克。
本发明还提供上述所述的螺旋藻多糖有机生物碘在制备用于抗辐射、 提高人体免 疫力、 抗癌或抗病毒的药品或保健食品中的应用。
其中, 上述所述的应用, 所述的辐射为电离辐射及核微量辐射或核能辐射。
具体而言, 从钝顶螺旋藻、 巨大螺旋藻或小球藻养殖池中→捞取新鲜藻泥→过塞 →放入容器中 (或另一藻池中) →配料: 以藻泥为载体, 藻泥要求 10-15公斤通过干 燥可还原成 1公斤藻粉的技术标准, 按比例添加提纯后的螺旋藻多糖和纯有机生物碘 粉 (发明专利号: ZL2003 1 0111222.2 ) →搅拌均匀同时→在日光或人造光源, 光照 强度 5-10万勒克司, 波长 400-700毫微米, 温控 30°C -40°C之间发生光学自养生物反 应过程→检测有机碘总碘含量 (以每克干粉含量从 5微克 -10万微克计算有效) 及螺 旋藻多糖含量(以每 100克干粉含 3-50克多糖为有效标准)达标后, 喷雾干燥或冷冻 干燥→成品包装→入库 15 °C -20°C恒温贮存。
本发明所述的螺旋藻多糖可以通过现有技术已知的螺旋藻多糖制取技术制备得 到。 例如:
A、粗提提取螺旋藻多糖 (polysaccharide οΐ Spirulina. PS)时先将螺旋藻干粉进行破壁处 理, 用低极性溶剂去亲脂性成分, 经热水抽提或碱液冷抽提 (可采用微波辅助提取) , 取上清液浓縮,乙醇醇析后离心、干燥得螺旋藻粗多糖。螺旋藻中蛋白质约占细胞干重 的 60〜70 % , 因此提取螺旋藻多糖关键是有效地去除蛋白质。
目前,去蛋白的方法主要有以下几种: Sevag 法、泡沫分离技术、三氯乙酸 (TCA) 法、 加热浓縮法、 酶法。 Sevag 法是去蛋白质的经典方法,通常只适用于除少量蛋白, 而且 必须重复多次。 TCA 法去蛋白能縮短流程, 多糖损失率降低,有利于后继纯化。 用酶法 降解蛋白质能提高多糖粗产品的得率, 但所得成分中仍有 30 %以上的蛋白质。采用双酶 法 (胰蛋白酶、 木瓜蛋白酶) 进行多糖提取工艺, 测得残留的蛋白质含量为 3 %。
B、 纯化
通过水提液抽提所得到的粗多糖可能含有多个混合糖组分及小分子杂质,须进一步 分级纯化才能得到螺旋藻多糖单一纯品。一般以层析后观察到单一狭窄的峰作为纯度鉴 定的标准。 常用的纯化方法有:
(1) 离子交换纤维素层析:离子交换和纤维素层析结合起来制成一系列离子交换纤 维素层析是基于树脂对不同离子的亲和力不同,溶出各种多糖,用于分离糖类。 分离过程 中常采用 NaCl 溶液或磷酸缓冲溶液梯度洗脱,可以得到不同级分的单一组分。常见的有 DEAE 纤维素、 以及 DEAE-Sepharose 。
(2) 凝胶过滤法:多糖制品经 DEAE 纤维素分离后,需进一步用凝胶过滤法纯化才能 得到均一多糖纯品。凝胶过滤法是一种用具有一定孔径大小的凝胶颗粒为支持物的层析 方法,可分离大小和形状不同的分子,用于分离不同聚合度的糖类特别有效。 葡聚糖凝胶 (Sephadex G),琼脂糖凝胶 (Sepharase),聚丙烯酰胺凝胶 (Bio-gel P) 均为亲水性凝胶,都广 泛应用于多糖的纯化。 螺旋藻多糖的纯化过程中一般采用 Sephadex G100 或 Sephadex G200、 Sepharyl S 100。 但 Sephadex G本身是糖类,难免在洗脱液中沾上自凝胶上洗脱下 来的糖分,可能会造成精制多糖的不纯。 纯化后多糖含量的测定用硫酸蒽酮法根踪检测。
本发明还提供一种更高效的螺旋藻多糖提取新工艺。 即采用双酶法 (胰蛋白酶、木 瓜蛋白酶) 进行多糖提取工艺, 脱蛋白效果接近 100 %, 粗多糖采用离子交换层析及 凝胶层析进一步纯化,并通过纸层析测其组成。通过 DEAE— Sep harose 和 Sep hadex -G50 纯化粗多糖,得到 2 个多糖组分。经测定组分 1的单糖组成为 D _葡葡糖、 D― 木糖、 D—半乳糖、 葡萄糖醛酸; 组分 2 的单糖组成为: D—葡萄糖、 D—甘露糖、 L一鼠李糖、 D—半乳糖、 葡萄糖醛酸。
螺旋藻粉→配成 12%的藻粉溶液→胰蛋白酶水解→木瓜蛋白酶水解→真空浓縮→ 酒精沉淀→丙酮洗涤→冷冻干燥→多糖粗制品多糖粗制品→离子交换层析→透析→凝 胶层析→冷冻干燥真空浓縮:在 70〜80 °C真空浓縮至含固形物 20 %。酒精沉淀分离:在浓 縮液中加入 5 倍体积的 95 %乙醇,使螺旋藻多糖呈絮状沉淀析出, 大部分蛋白质和其它 成分保留在溶液中, 4000r/min 离心 15min得沉淀。
蛋白质测定凯式定氮法。
胰蛋白酶最适作用温度的确定, 胰蛋白酶的最适作用温度为 55 V, 此时酶解脱蛋 白效果最好。
胰蛋白酶最适作用 pH 值的确定, 胰蛋白酶在 6.2〜7.2 的范围内具有较高的酶活 力。
胰蛋白酶酶解时间的确定, 胰蛋白酶作用 2.5h后多糖粗产品中蛋白质含量不再有 明显下降, 因此蛋白酶作用 2.5h后可中止反应。
胰蛋白酶最适作用量的确定, 酶用量达到 3.0%以后脱蛋白效果不再明显增加, 所 以酶用量确定为 3.0%。
利用木瓜蛋白酶进行二次水解
加酶量 3% , 在 pH6.5 的缓冲液中, 40 °C,保温 20h , 经常振摇。
酶解液经真空浓縮、 酒精沉淀后, 测得残留蛋白质含量为 3%。
离子交换层析分离多糖
采用 DEAE— Sepharose 柱 (20 X lcm) 进行多糖分离: 用 0.01mol/L 、 p H8.0 的 吡啶一盐酸缓冲液平衡离子交换柱,粗多糖的上样量为 8mL,流速为 25mL/h,用 O.Olmol /L 、 pH8.0 的吡啶一盐酸缓冲液及 0〜2mol/L 的 NaCl 进行梯度洗脱, 得图 1 所示曲 线。 将该曲线的两个峰分别收集, 冷冻干燥得 粗组分 1 和粗组分 2。
凝胶层析分离多糖
采用 Sephadex-G50 凝胶柱 (90 X2cm) 进行多糖粗组分 1 和多糖粗组分 2 的分 离, 洗脱液为蒸馏水, 流速 25mL/h , 得图 2、 图 3 所示曲线。 分别收集单一溶液, 冷 冻干燥后得多糖纯组分 1 和纯组分 2。
多糖样品经酸解、 纸层析得单糖组成为: 组分 1 为 D—葡萄糖、 D—木糖、 D—半 乳糖、 葡萄糖醛酸; 组分 2 为 D—葡萄糖、 D—甘露糖、 L—鼠李糖、 D—半乳糖、 葡 萄糖醛酸。 本发明的螺旋藻多糖有机生物碘可作为食用和医用, 可生产出抗辐射螺旋藻多糖 有机生物碘片、 胶囊、 颗粒丸、 散冲剂、 口服液、 滴定液等系列产品。
本发明的抗核辐射的产品中的有机碘含量按照我国卫生部最新指定标准添加制 成, 其中 3岁以下儿童 25毫克 (即 25000微克), 成人 100毫克 (即 100000微克), 孕产妇和 3-12岁儿童 50毫克 (即 50000微克); 成人一次摄食量 100毫克相当于五 公斤碘盐总碘量。
在制备上述抗核辐射产品中, 可采用现有的药品微囊生产技术及现有的碘化油丸 生产技术。 其中, 将原碘化油丸中的核桃油及豆油删除, 改为使用橄榄油 (其不饱和 脂肪酸质优含量高), 有益于心脏和血管呵护, 可达到人体缓慢吸收有效碘的目的, 以求更有效安全对抗辐射碘。 对于核能即将发生前 24-48小时之内, 可将上述一次性 食用量配制成 2-3次服用量, 取代缓释剂效果。
抗核微量辐射、 抗电离辐射及化疗产品含天然螺旋藻多糖在 3-12g, 其有机碘含 量通用性产品按每克含 5微克配制, 适合任何人群。 为增加抗癌抗肿瘤效果, 螺旋藻 多糖含量在 12-50g。
核辐射除碘 131外, 还有铯 -137、 氮 -16、 氚, 放射性物质也会对人体造成伤害, 有机生物碘与螺旋藻多糖的联合对抗可减少其对人体伤害程度。有机生物碘及螺旋藻 多糖在过量状态下, 不仅充盈甲状腺中, 还布满在人体全身脂肪酸内及血液中, 起到 适量保护皮肤、 骨骼、 血液、 五脏之功效。 对防治白血病等有一定效果。 添加螺旋藻 藻兰素及叶绿素后, 具有排毒排重金属及放射性体内积存物功效。
本发明所述的螺旋藻多糖有机生物碘可作食疗保健食品, 用于抗核微量辐射、抗 电离辐射及化疗使用及提高人体免疫力及抗癌抗病毒功能。
本发明所述的螺旋藻多糖有机生物碘可作药品使用,用于对抗核能辐射预防及治 疗, 抢救灾民, 减少癌变发病率, 提高人体免疫力, 优于现有技术 "稳定碘" (即碘 化钾和碘酸钾片) 的防治效果, 造福于人类健康。
本发明的螺旋藻多糖有机生物碘, 根据小鼠急性毒性试验检测 "超人螺旋藻粉" (富碘多糖型)(98 )粤卫防食毒检字第 A022号报告, 属无毒级物质及山东省青岛市 疾病控制中心 2003CT00019 "食用高碘螺旋藻初步稳定性试验" 报告, 经国家科学 技术委员会轻科鉴字 [199]第 014号科学技术成果鉴定证书,成果鉴定为将其加入食盐 和其他食品中制成补碘食品, 在国内外未发现同类产品, 是一项创新, 是一种安全的 补碘食品。 有机碘盐已售市 11年, 无一例毒副作用, 深受用户好评。 附图说明
图 1 : DEAE— Sepharose 柱洗脱曲线;
图 2: 多糖组分 1 的 Sephadex - G50 柱洗脱曲线;
图 3 : 多糖组分 2 的 Sephadex - G50 柱洗脱曲线。
图 4: SPP对 PBMC和 K562细胞细胞毒作用
图 5 : SPP孵育时间与 ΝΚ活性关系 具体实施方式
实施例一: 抗核微量辐射、 抗家电、 通讯、 化疗电离辐射, 螺旋藻多糖有机生物 碘配制方法:
从小球藻养殖池中捞取新鲜活体藻泥→过塞→放入容器中 (或另一藻池中) 以藻 泥为载体, 配料配方换算比例: 其藻泥每 10-15公斤经喷雾干燥或冷冻干燥后可成 1 公斤藻干粉, 同时按每 10-15公斤藻泥添加 30-500克螺旋藻多糖, 同时添加纯有机生 物碘粉 lg含 1-5微克后→搅拌均匀同时→在日光或人造光源 (光照强度 5-10万勒克 司, 波长 400-700毫微米) 温控 30°C-40°C之间→发生光学自养生物反应→喷雾干燥 或冷冻干燥成螺旋藻干粉后, 测出有机碘总碘每 100克含量 100-500微克, 干藻粉螺 旋藻多糖每 100克含量 3-50克,即为合格产品→成品包装→入库 15 °C -20°C恒温贮存。
上述产品为抗核微量辐射、 抗手机、 电脑、 家电、 化疗后辐射 (该产品适合任何 人群服用, 不受年龄性别限制)。
实施例二: 抗核微量辐射、 抗家电、 通讯、 化疗电离辐射, 螺旋藻多糖有机生物 碘配制方法 (补碘型, 不同年龄段食用量见说明书):
从小球藻养殖池中捞取新鲜活体藻泥→过塞→放入容器中 (或另一藻池中) 以藻 泥为载体, 配料配方换算比例: 其藻泥每 10-15公斤经喷雾干燥或冷冻干燥后可成 1 公斤藻干粉, 同时按每 10-15公斤藻泥添加 30-500克螺旋藻多糖, 同时添加纯有机生 物碘粉 lg含 20-50微克后→搅拌均匀同时→在日光或人造光源 (光照强度 5-10万勒 克司, 波长 400-700毫微米) 温控 30°C -40°C之间→发生光学自养生物反应→喷雾干 燥或冷冻干燥成螺旋藻干粉后, 测出有机碘总碘每 100克含量 2000-5000微克, 干藻 粉螺旋藻多糖每 100克含量 3-50克, 即为合格产品→成品包装→入库 15 °C -20°C恒温 贮存。 实施例三: 抗核辐射螺旋藻多糖有机生物碘配制方法:
从钝顶螺旋藻养殖池中捞取新鲜活体藻泥→过塞→放入容器中 (或另一藻池中) 以藻泥为载体, 配料配方比例: 其比例每 10-15公斤经冷冻干燥后可成 1公斤螺旋藻 干粉, 同时按每 10-15公斤藻泥添加纯有机生物碘粉, 使终端产品可达到成年人 (每 克干藻粉含 10万微克有机碘) 或孕产妇和 3-12岁儿童 (每克干藻粉含 5万微克有机 碘), 或 3岁以下儿童 (每克干藻粉含 2.5万微克有机碘), 同时按每 10-15公斤藻泥 添加 300-500克螺旋藻多糖后→搅拌均匀同时, 在日光或人造光源(光照强度 5-10万 勒克司, 波长 400-700毫微米) 温控 30°C -40°C之间→发生光学自养生物反应→喷雾 干燥成螺旋藻干粉后→测出有机碘总碘总量, 达到标准 (成人、 孕产妇、 儿童, 世界 卫生组织要求含量规定) 即为合格→成品包装→入库 15 °C -20°C恒温贮存。若配料时, 添加藻蓝素及叶绿素, 即具有排毒排体内辐射沉积物功能。
实施例四: 抗核辐射螺旋藻多糖有机生物碘配制方法:
从巨大螺旋藻养殖池中捞取新鲜活体藻泥→过塞→放入容器中 (或另一藻池中) 以藻 泥为载体,配料配方比例:其比例每 10-15公斤经冷冻干燥后可成 1公斤螺旋藻干粉, 同时按每 10-15公斤藻泥添加纯有机生物碘粉, 使终端产品可达到成年人 (每干藻粉 含 10万微克有机碘)或孕产妇和 3-12岁儿童 (每克干藻粉含 5万微克有机碘), 3岁 以下儿童 (每克干藻粉含 2.5万微克有机碘), 同时按每 10-15公斤藻泥添加 300-500 克螺旋藻多糖后→搅拌均匀同时, 在日光或人造光源(光照强度 5-10万勒克司, 波长
400-700毫微米)温控 30°C -40°C之间→发生光学自养生物反应→喷雾干燥成螺旋藻干 粉后→测出有机碘总碘总量, 达到标准 (成人、 孕产妇、 儿童, 世界卫生组织要求含 量规定) 即为合格→成品包装→入库 15 °C -20°C恒温贮存。 若配料时, 添加一定比例 的藻蓝素及叶绿素, 使其具有排毒排体内积存辐射积存物, 从大小便中排出。
实施例五: 抗辐射螺旋藻多糖有机生物碘效果试验:
超过常人 40倍
赵波食用过量有机生物碘临床报告
一、 目的:
用自己身体, 作人体吸收实验, 证明有机生物碘能被人体吸收; 作人体过量服用 有机生物碘实验, 证明对人体无害。 为抗核辐射制成有机碘片达到卫生部规定标准量 提供依据。
二、 试验难度:
本试验国内外为 "首创", 任何检测或卫生部门没有做过此同类试验, 谁也不能 "以身试验", 承担由此引起的人身安全和事故责任。
三、 指导思想: 经 5年来食用高剂量有机碘没有发现危害, 通过试验获得卫生部的添加量, 为配 制成抗核爆有机碘提供依据。
赵波服用超过常人 40倍碘含量验单分析报告 (仅供参考)
Figure imgf000015_0001
四、 超过常人 40倍碘含量试前准备:
Figure imgf000015_0002
六、 超过常人 40倍碘含量服后反应观察:
观 察 内 脉搏 心跳 呼 饮食 睡 眼 甲状腺 小便 大便
容 次 1 次 /分 吸 眠 睛
服用 时 分钟 钟
( 98年) 8日早晨 76 76 正 正常 正 正 正常 正常 正常
9点服用 常 常 常
9日早晨 76 76 正 正常 正 干 喉结正 尿长 时间长, 有点便结
9点服用 常 稍渴 常 涩 常无异 带黄
反应
10 日早 75 75 正 正常 正 巨 同上 同上 便结, 成算盘状 晨 常 多 饮 常 转
9点服用 水 赤
11 日早 76 76 正 正常 失 巨 同上 同上 大便困难,时间加长, 晨 常 多 饮 眠 赤 涂肥皂抹肛门, 用手
9点服用 水 干 扣出
12 日早 78 78 正 正常 正 巨 同上 同上 大便困难,时间加长, 晨 常 多 饮 常 赤 涂肥皂抹肛门, 用手
9点服用 水 泛 扣出落便池肛铛啷有 红 声
13 日早 77 77 正 正常 正 同 同上 同上 解完大汗淋淋有痛感 晨 常 多 饮 常 上
9点服用 水
14 日停 75 75 正 正常 正 巨 同上 同上 靠指扣出, 有痛感 服 常 多 饮 常 赤
水 干
15 日停 74 74 正 正常 正 巨 同上 同上 大便时间减少, 仍便 服 常 多 饮 常 赤 结
水 好
16 日停 74 74 正 正常 正 巨 同上 同上 大便渐渐恢复正常 服 常 常 赤
17 日停 74 74 正 正常 正 正 正常 正常 正常
服 常 常 常 六、 目赤与便结产生原因分析及应变措施:
高浓度碘化物进入人体及血液中, 通过血液循环引起眼睛视网膜充血, 吸收周边 水份, 产生充血与干燥感: 高浓度碘化物进入肠道系统, 因碘化物具有极大吸附性, 将肠壁与水分吸附干净引起便秘所致。
其应变措施, 我吞饮大量水及雪糕、蜂蜜及香蕉, 在试验做完以后, 为缓解便结, 在 9月 15日以后几天服用少许 "牛黄解毒丸"、 广州五羊牌 "湿热清"及 "夏桑菊" 冲剂, 即恢复正常。
七、 检验报告书结果分析
Figure imgf000017_0001
八、 上述试验解读
8.1 由前四年的连续服用,体内已产生上百万的碘离子,后六连续服用每天 8000 微克碘离子, 因此产生了副作用, 停服后副作用消失。
8.2 连续服用六天的实验总量为 54000微克, 符合卫生部孕产妇和 3-12岁儿童 (每克干藻粉含 5万微克有机碘), 3岁以下儿童 (每克干藻粉含 2.5万微克有机碘) 标准, 此案例起到了替代缓释剂的效果。
8.3 由于服用过量碘化物, 其尿碘检测结果为 7954微克。 (附 98年 10月 15 日 检验报告书)
实施例六: 盐用富碘螺旋藻粉 (高剂量组) 抗辐射有机碘解读:
本检测报告单由江西省疾病预防控制中心出具, 样品编号: 食 20091351, 食 检验依据: GB15193-2003 《食品安全性毒理学评程序和方法》
毒理学检验结论:
1、 急性经口毒性试验: 盐用富碘螺旋藻粉对雌雄性小鼠急性经口毒性 MTD均大于
10g/kgBW,属实际无毒。
2、 小鼠骨髓嗜多染红细胞微核试验: 小鼠骨髓嗜多染红细胞微核试验结果为阴性。
3、 小鼠精子畸形试验: 小鼠精子畸形试验结果为阴性。
4、 Ames试验: Ames试验结果为阴性。
5、 大鼠 30天喂养试验:各剂量组动物体重、 食物利用率、 主要脏体比与对照组比较 差异无显著性(P〉0.05)。对照组和各剂量组的白细胞计数及其分类、 红细胞计 数、 血红蛋白及各项生化指标 (谷丙转氨酸、 谷草转氨酸、 尿素氮、 肌酐、 胆 固醇、 甘油三酯、 血糖、 总蛋白、 白蛋白) 均在本实验室正常参考值范围内。 各组动物大体解剖与主要脏器病理组织检查均未见有意义的病理变化。
每只老鼠每天食用量: 84700微克, 连续服用 30天, 共 2541000微克。 各组动 物大体解剖与主要脏器病理组织检查均未见有意义的病理变化。 没有发生中毒, 没有 发生病变。 由此可推断, 成人每次服用 100000微克是安全的。 用此剂量可达到卫生 部成人、 孕产妇、 儿童服用抗核爆标准用量。
实施例七: 钝顶螺旋藻多糖抗辐射效果试验数据
钝顶螺旋藻多糖对小鼠外周血细胞及骨髓有核细胞数的影响 (X士 s) 指标 伤 后 时 间 正常对照组 正常用药组 辐射对照组 辐射损伤用
(d) 药组
Hb 5 142.82 + 144.93 + 86.33 + 88.52 +
(g/L) 10 10.63 13.82 15.21ΔΔ 16.13 n=18~21 15 139.12士 141.15士 96.45 + 105.91 +
WBC 5 15.46 10.03 12.38ΔΔ 13.42
(IXIOVL) 10 148.22 + 145.29士 145.16士 143.67士 n=18~21 15 11.24 12.19 15.94 15.66
PLT 5 8·42±2·34 8·71±2·23 3·57±0· 94Δ 3·86±1·43
(IXIOVL) 10 8·25±2·71 8·39±2·16 7.68 ±2· 55" n=18~21 15 8·32±2·65 8·29±2·81 5·72±2· 81Δ 8.41 ±2.48
BMC 5 261.23士 248.6士 25.63士
(1X107根) 10 46.38 44.65 8·35±2·37 11.74 n=10~18 15 255.34士 257 ±47.25 26.83 + 95.78士
51.27 253 + 46.62 14.85ΔΔ 29.61
258.37士 13·55±3· 78 98.65士 245.44 +
48.26 31.17ΔΔ 47.22
10·16±4·81 13·35±1· 19 243.64士 6.18 ±2· 39"
10·51±1·69 51.68 9.34 ±4.34"
10·46±4·11 13·37±3· 55 3·26±1· 72Δ 10.32±4.08
7·12±3· 85Δ
10·47±4·62
注: 与正常对照组比较, Δρ<0.05, ΔΔρ<0.01; 与辐射损伤对照组比较 〈0.05 ρ〈0.01 表 2 钝顶螺旋藻多糖对小鼠造血组细胞及造血干细胞数的 响 (X士 s)
Figure imgf000019_0001
n=10~13 15 18.21 11.26Δ 12.73 8.65*
CFU-S 66·51±6·25 88·62±5·18 12·32±7· 63 42.12士
(1X10¾MC) 62·25±7·23 10.68" n=8 65·53±7·15 85.81 + 7.21 23·92±8· 65 66.38士
12.85±5.61 11.82
13·11±6·82 85·49±7·82 64.25 ±8.94 9·54±5· 28*
13·15±4·77 6·18±4· 25Δ 12.74士
15.78±5.27 5.84"
9.04±5.27Δ 13·35±5· 71
15.93 + 4.04
13·13±4·69
15·52±5· 15 注: 与正常对照组比较, Δρ<0.05, ΔΔρ<0.01; 与辐射损伤对照组比较 〈0.05 ρ〈0.01 实施例八: 螺旋藻抗辐射效果试验数据
表 1 螺旋藻对 6QCo-r辐照小鼠骨髓红细胞
微核率的影响 (X±s
Figure imgf000020_0001
与对照组比较, a: 7<0.01,b: 与高剂量组比较, 7<0.005<
表 2 螺旋藻对 6QCo-r辐照小鼠睾丸精母
细胞染色体畸变的影响
染色体畸变数
剂量 (g/kg) 畸变细胞率 (%)
(包括断片及易位)
低剂量组 0.4 75 7.5 中剂量组 1.2 50 5.0b 高剂量组 2.4 36 3.6ac 辐照对照 0.0 80 8.0d 空白对照 0.0 3 0.30 与辐射对照组比较, a: 7<0.01,b: p<0.005; 与低剂量组比较,
c: 7<0.001;与空白对照组比较, d: 7<0.01. 实施例九: 钝顶螺旋藻多糖抗辐射对急性白血病病人 NK细胞的作用
图 4 SPP对 PBMC和 K562细胞细胞毒作用;
2.2.2 SPP作用时间与 ΝΚ细胞活性关系
10mg ·Ι SPP加入 NK效应细胞孵育不同时间对 NK细胞活性影响见图 5, 说明 效应细胞加 SPP作用 12h以上始有效果,24h达较高水平,故本实验选孵育时间为 24h。
附表 SPP对白血病病人 NK细胞活性
Figure imgf000021_0001
注: <0.01, *>>0.05 正常人
SPP孵育时间 (h)
图 5 SPP孵育时间与 NK活性关系
2.2.3 SPP对正常人 NK细胞活性影响
正常人外周血单个核细胞加入 SPPlOmg · L- 1后 NK细胞活性为 46.70±10.56% 与正常人 NK细胞活性相比较差异无显著性 (ρ〉0.05) ,说明该浓度 SPP对正常人 ΝΚ 细胞活性无明显影响。
2.3 SPP对白血病病人 ΝΚ细胞活性作用
SPP使 31例白血病病人外周血 ΝΚ细胞活性从 26.41 ±10.17%提高到 38.33 + 9.45% (ρ<0Μ), 但仍低于正常人 NK细胞活性 (ρ<0.01), 不同病期急性白血病病 人外周血单个核细胞加入 SPP后 ΝΚ细胞活性均有明显提高 (ρ<0.01)。 初发、 复发 期病人 ΝΚ细胞活性加 SPP后虽有提高但仍低于正常人(ρ<0.01 ),而缓解期病人 ΝΚ 细胞活性加 SPP后与正常人相比较则差异无显著性 (ρ〉0.05), 见附表。
实施例十: 螺旋藻多糖对抗紫外线辐射
3 结果
3.1给药组的最佳浓度:在 96空板中加入药物,对细胞进行培养, 与对照组相比, 各药物浓度组细胞生长不一, 其中 1600、 800 g ' L-1剂量组细胞于接种后第 2天即出 现细胞圆縮难以粘壁, 第 3天见培养液内细胞残渣, 各药物剂量组于接种后第 4天进 行细胞计数, 结果见表 1, 从而确定 PSP的给药剂量为 100、 50、 25 g · L- 表 1 不同 PSP浓度对细胞生长的影响 (Xis) ―
PSP浓度 ( g · L— n 细胞密度 (1 106个/1^)
0 8 1.8±0· 075
25 8 3.2±0· 142
50 8 3.0±0· 102
100 8 3.0±0· 149
200 8 1.4±0· 127
400 8 0.8±0.093 3-2 DNA损伤实验
在确定好药物浓度后,取细胞以 l X 106/cm2的密度接种于 25mL的培养瓶中,仍 用含 10%的胎牛血清, 0.3%的 L-谷氨酰胺, 100U · ΜΓ1的青霉素和 lOOmg · L 1的链 霉素培养, 并分别设对照组和加入 100,50,25 mg - L"1的 PSP给药组进行培养, 细胞在 培养 4d后, 于 UV下照射 30min,进行铺片, 变性, 解旋, 电泳, 中和, 染色, 观察 及拍片, 并在每张载玻片上随机选择 10个细胞进行测量, 对照组和各给药组的 DNA 迁移距离 (MLD ) 如表 2, 各给药组的 MLD与对照组相比, MLD明显减少, 且在统 计学有明显差异
PSP对紫外线照射 30min后细胞的 MLD的影响 (X士 s) ―
Figure imgf000022_0001
3-3 DNA基础水平损伤及损伤后修复
在基础水平损伤后再给予 PSP进行培养, 损伤后 30,60,90min各时间进行 SCGE, 各组细胞及各时间的 MLD如表 3, 图 4。
表 3 UV诱发的 DNA基础损伤时的 MLD及之后给予 PSP各时间的 MLD^m ( X士 s) ―
Figure imgf000022_0002
*p<0.05,**p<0.01 vt 对照组

Claims

权 利 要 求 书
1、 一种螺旋藻多糖有机生物碘, 其特征在于以新鲜活体藻泥为载体, 加入螺旋 藻多糖和有机生物碘, 在光照和温控下发生光学自养生物反应而得到螺旋藻多糖有机 生物碘。
2、 根据权利要求 1 所述的螺旋藻多糖有机生物碘, 其特征在于所述的螺旋藻多 糖有机生物碘的配比为: 藻泥占 50-96%, 螺旋藻多糖占 3-50%, 有机生物碘占 0.0001 -10%
3、 根据权利要求 1 所述的螺旋藻多糖有机生物碘, 其特征在于所述的藻泥选自 钝顶螺旋藻、 巨大螺旋藻或小球藻。
4、 根据权利要求 1 所述的螺旋藻多糖有机生物碘, 其特征在于所述的有机生物 碘由 96 %的 1-碘酪氨酸、 2 %的 2-碘酪氨酸和 2 %的海藻酸钠组成。
5、 根据权利要求 1所述的螺旋藻多糖有机生物碘, 其特征在于所述的螺旋藻多 糖是由螺旋藻粉经酶水解、 醇沉和柱层析纯化步骤制得的, 其中所述的酶为胰蛋白酶 和木瓜蛋白酶。
6、 根据权利要求 1所述的螺旋藻多糖有机生物碘, 其特征在于所述的光照为日 光或人造光源, 其光照强度 5-10万勒克司, 波长 400-700毫微米。
7、 根据权利要求 1 所述的螺旋藻多糖有机生物碘, 其特征在于所述的温控是温 度在 30°C -40°C之间。
8、根据权利要求 1-7任一项所述的螺旋藻多糖有机生物碘,其特征在于以藻泥的 干粉计算, 每 100g 藻泥干粉, 加入螺旋藻多糖 3-50 克, 有机生物碘以碘计算 100-10,000,000微克。
9、 根据权利要求 1一 8任一项所述的螺旋藻多糖有机生物碘在制备用于抗辐射、 提高人体免疫力、 抗癌或抗病毒的药品或保健食品中的应用。
10、 根据权利要求 9所述的应用, 其中所述的辐射为电离辐射及核微量辐射或核 能辐射。
PCT/CN2012/073504 2011-06-08 2012-04-05 抗辐射螺旋藻多糖有机生物碘及其应用 WO2012167656A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110151289.3 2011-06-08
CN2011101512893A CN102319255B (zh) 2011-06-08 2011-06-08 抗辐射螺旋藻多糖有机生物碘及其应用

Publications (1)

Publication Number Publication Date
WO2012167656A1 true WO2012167656A1 (zh) 2012-12-13

Family

ID=45447182

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/073504 WO2012167656A1 (zh) 2011-06-08 2012-04-05 抗辐射螺旋藻多糖有机生物碘及其应用

Country Status (3)

Country Link
CN (1) CN102319255B (zh)
HK (1) HK1163522A1 (zh)
WO (1) WO2012167656A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319255B (zh) * 2011-06-08 2013-03-27 深圳市兆博有机生物碘盐技术开发中心 抗辐射螺旋藻多糖有机生物碘及其应用
CN102851345B (zh) * 2012-08-31 2014-07-30 华南理工大学 小球藻抗肿瘤多肽的制备方法
CN103013726B (zh) * 2012-12-12 2017-07-11 赵波 藻蓝多糖绿啤及酒类和饮料及其制备方法
CN103923858A (zh) * 2014-04-24 2014-07-16 周霞轩 一种富碘蓝藻纯顶螺旋藻碘盐的养殖方法
CN107080223A (zh) * 2017-01-09 2017-08-22 深圳震乾坤生物科技有限公司 海藻有机碘粉和海藻有机碘盐制备方法及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6181776A (ja) * 1984-09-28 1986-04-25 Takashi Oritani 藍藻類の製造方法
CN1173989A (zh) * 1996-12-03 1998-02-25 赵波 螺旋藻活性碘盐调味品食品饮料配制方法
CN1217658C (zh) * 2003-10-10 2005-09-07 赵波 有机生物碘及其应用
CN102319255A (zh) * 2011-06-08 2012-01-18 赵波 抗辐射螺旋藻多糖有机生物碘及其应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6181776A (ja) * 1984-09-28 1986-04-25 Takashi Oritani 藍藻類の製造方法
CN1173989A (zh) * 1996-12-03 1998-02-25 赵波 螺旋藻活性碘盐调味品食品饮料配制方法
CN1217658C (zh) * 2003-10-10 2005-09-07 赵波 有机生物碘及其应用
CN102319255A (zh) * 2011-06-08 2012-01-18 赵波 抗辐射螺旋藻多糖有机生物碘及其应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SUN XIANGJUN.: "New process for separation & purification of polysaccharide from spirulina platensis.", FOOD SCIENCE AND TECHNOLOGY., 20 March 2000 (2000-03-20), pages 32 - 34 *
YOU SHAN ET AL.: "A survey of researches on bioactivities of polysaccharide from spirulina platensis.", BIOTECHNOLOGY., 20 December 2002 (2002-12-20), pages 2 - 3 *

Also Published As

Publication number Publication date
CN102319255A (zh) 2012-01-18
CN102319255B (zh) 2013-03-27
HK1163522A1 (en) 2012-09-14

Similar Documents

Publication Publication Date Title
CN102114044B (zh) 一种人工加工熊胆粉及其制备方法
CN103750339B (zh) 雪莲培养物保健食品及其用途
WO2012167656A1 (zh) 抗辐射螺旋藻多糖有机生物碘及其应用
CN105816430B (zh) 一种具有抗肿瘤作用三叶青多糖颗粒的制备方法
CN103181565A (zh) 防pm2.5清肺护肺胶囊
CN108813610A (zh) 一种用于提高免疫力的雪莲组合物及其应用
CN104667135A (zh) 一种药物组合物、保健品及制备方法
CN107812016B (zh) 一种美洲大蠊提取物、制备方法及其在免疫调节中的应用
CN102114067B (zh) 复方林蛙油冲剂及其应用
AU2012325600B2 (en) Pharmaceutical composition regulating blood fat and preparation process thereof
CN102008563B (zh) 一种抗癌中药及其配制方法
CN102283885A (zh) 一种当归补血汤整合型新剂型制备技术及其生产方法
CN103829254A (zh) 一种原花青素在制备减肥食品或药品中的应用
CN106309758A (zh) 一种抗胃肠癌的药物组合物
CN103768570B (zh) 一种治疗急性胆囊炎的中药组合物及其制备方法
CN101502536B (zh) 香柏总黄酮及其制备方法与医药用途
CN104069149A (zh) 一种采用熊胆为基质的中药饮片炮制方法
CN112057476B (zh) 一种组合物及其在醒酒解宿醉护胃上的应用
CN108095082A (zh) 一种含有姜黄素的保健食品及其制备方法
CN107802726A (zh) 一种覆盆子保健品及其制备方法
CN102727867A (zh) 一种抗肿瘤用药物组合物及应用、试剂盒及包装件
CN106727634A (zh) 人参皂苷Rg1及PPT作为非经典炎症小体抑制剂的应用
CN107252454B (zh) 一种含有黑茶提取物的药品组合物在治疗脓毒症中的应用
Baqa et al. Nutritional treatment of anaemia as compare to marketed available drug (ferrous sulfate) in animal model
CN114177208A (zh) 释迦核乙醇提取物在制备降脂减肥药物中的应用

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12796500

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22/05/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12796500

Country of ref document: EP

Kind code of ref document: A1